In our study, it appeared that PSVII could downregulate p-STAT3, NFκB, p-NFκB, IKKβ, p-IKKβ, and IκBα, offering preliminary evidence that PSVII likely modulates psoriasis by targeting the STAT3/NFκB signaling pathway. Here, NFKB1 is linked to psoriasis.